338 related articles for article (PubMed ID: 11592805)
1. Dystrophin and muscular dystrophy: past, present, and future.
O'Brien KF; Kunkel LM
Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
[TBL] [Abstract][Full Text] [Related]
2. [Molecular therapy of muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
[TBL] [Abstract][Full Text] [Related]
3. [Updates in muscular dystrophies].
Erazo-Torricelli R
Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
[TBL] [Abstract][Full Text] [Related]
4. Duchenne muscular dystrophy.
Gorospe JR; Hoffman EP
Curr Opin Rheumatol; 1992 Dec; 4(6):794-800. PubMed ID: 1457273
[TBL] [Abstract][Full Text] [Related]
5. Patient page. Gene therapy and muscular dystrophies.
Karceski S
Neurology; 2008 Jul; 71(4):e6-8. PubMed ID: 18645160
[No Abstract] [Full Text] [Related]
6. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in the biology of dystrophin and related molecules.
Karpati G
Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):615-21. PubMed ID: 1392135
[TBL] [Abstract][Full Text] [Related]
8. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
Stedman HH
Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
[TBL] [Abstract][Full Text] [Related]
9. [Dystrophin gene expression in patients with Duchenne muscular dystrophy after myoblast transplantation].
Shishkin SS; Terekhov SM; Krokhina TB; Shakhovskaia NI; Podobedova AN; Linnaia GF; Tarasov VI; Ovchinnikov VI; Krakhmaleva IN; Zakharov SF; Ershova ES; Limborskaia SA; Pogoda TV; Zotikov EA; Kut'ina RM; Tarksh MA; Sukhorukov VS; Gerasimova NL
Genetika; 2001 Aug; 37(8):1104-11. PubMed ID: 11642111
[TBL] [Abstract][Full Text] [Related]
10. Etiology and pathogenesis of the muscular dystrophies.
Van den Bergh PY; Tomé FM; Fardeau M
Acta Neurol Belg; 1995; 95(3):123-41. PubMed ID: 7484050
[TBL] [Abstract][Full Text] [Related]
11. Function and genetics of dystrophin and dystrophin-related proteins in muscle.
Blake DJ; Weir A; Newey SE; Davies KE
Physiol Rev; 2002 Apr; 82(2):291-329. PubMed ID: 11917091
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic strategy for muscular dystrophies].
Shin JH; Takeda S
Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
[TBL] [Abstract][Full Text] [Related]
14. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
Navarro C
Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
[TBL] [Abstract][Full Text] [Related]
15. The future of Duchenne muscular dystrophy gene therapy: shrinking the dystrophin gene.
Roberts M; Dickson G
Curr Opin Mol Ther; 2002 Aug; 4(4):343-8. PubMed ID: 12222872
[TBL] [Abstract][Full Text] [Related]
16. Full-length dystrophin gene transfer to the mdx mouse in utero.
Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for muscular disease.
Johnston N
Drug Discov Today; 2004 Sep; 9(18):777. PubMed ID: 15364061
[No Abstract] [Full Text] [Related]
18. Gene therapy for muscular dystrophy: current progress and future prospects.
Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy progress and prospects: Duchenne muscular dystrophy.
Foster K; Foster H; Dickson JG
Gene Ther; 2006 Dec; 13(24):1677-85. PubMed ID: 17066097
[TBL] [Abstract][Full Text] [Related]
20. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
